(US) /    Tel: (781) 999-4286 / (781) 999-5354
Home > VEGFR
Cat.No. Product Name Information Area
T5153 Apatinib mesylate Apatinib is an orally bioavailable and specific VEGFR2 inhibitor (IC50: 1 nM). In add... Cancer
T4026 VEGFR2 KiN/Ase Inhibitor I VEGFR2 Kinase Inhibitor I is a potent, cell-permeable inhibitor of the VEGFR2 kinase. Others
T3980 Su1498 SU 1498 is a selective inhibitor of the receptor tyrosine kinase VEGF receptor 2 (VEG... Others
T3571 NSC 247030 NSC 247030 is a biochemical. Others
T3560 Desmethylanethol trithione ADT-OH is a derivative of anethole dithiolethione (ADT) and synthetic hydrogen sulfid... Others
T3463 NVP-ACC789 ACC-789 (NVP-ACC789; ZK-202650) is an effective, specific and orally active inhibitor... Others
T3476 JI-101 JI-101 is an oral multi-kinase inhibitor that targets vascular endothelial growth fac... Cardiovascular
T3691 SAR131675 SAR131675 is an effective and specific VEGFR-3 inhibitor. It inhibited VEGFR-3 tyrosi... Others
T3599 BFH772 BFH772, a structure analogue of BAW2881, is a potent and selective VEGF inhibitor. BF... Immunology
T3641 BAW2881 BAW2881 is a potent and selective VEGFR inhibitor (vascular endothelial growth factor... Others
T6996 SU5402 SU5402 is a potent multi-targeted receptor tyrosine kinase inhibitor with IC50 of 20 ... Others
T6930 Pazopanib HCl Pazopanib HCl (GW786034 HCl) is a novel multi-target inhibitor of VEGFR1, VEGFR2, VEG... Others
T1797 XL184 Cabozantinib S-malate is the s-malate salt form of cabozantinib, an orally bioavailab... Cancer
T2288 Motesanib Motesanib is an orally bioavailable receptor tyrosine kinase inhibitor with potential... Cancer
T6720 Vatalanib 2HCl Vatalanib (PTK787) (IC50=37 nM) is an inhibitor of VEGFR2/KDR. It exhibits less effec... Cancer
T6184 Orantinib TSU-68,a excellent effective against PDGFR autophosphorylation with Ki of 8 nM, also ... Cancer
T6166 Telatinib Telatinib is an effective inhibitor of VEGFR2/3, c-Kit, and PDGFRα. The IC50s of Tela... Cancer
T6036 Brivanib Brivanib is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate ... Cancer
T3068 AT9283 AT9283 is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1... Cancer
T2699 BMS-777607 BMS-777607 is a Met-related inhibitor for c-Met/Axl/Ron/Tyro3 (IC50: 3.9/1.1/1.8/4.3 ... Endocrine system
T2656 Fruquintinib Fruquintinib is an orally available, small molecule inhibitor of vascular endothelial... Cancer
T2642 PD173074 PD173074 is an effective FGFR1 inhibitor (IC50: 25 nM) and also inhibits VEGFR2 (IC50... Cancer
T2620 G-749 G-749, a new-type FLT3 inhibitor, exhibits effective and sustained inhibition of the ... Cardiovascular System
T2586 Cabozantinib Cabozantinib (XL184) is a potent pan-tyrosine kinases inhibitor that inhibits VEGFR2,... Cancer
T2582 Apatinib Apatinib is an orally bioavailable and specific VEGFR2 inhibitor (IC50: 1 nM). In add... Cancer
T2576 Brivanib Alaninate Brivanib Alaninate is the alaninate salt of a vascular endothelial growth factor rece... Cancer
T2514 Linifanib Linifanib (ABT-869) is a novel, potent ATP-competitive VEGFR/PDGFR inhibitor for KDR ... Cancer
T2500 Cediranib Cediranib (AZD2171) is a highly potent (IC50 < 1 nmol/L) ATP-competitive inhibitor of... Cancer
T2496 Semaxanib Semaxanib (SU5416) is a potent and selective VEGFR(Flk-1/KDR) inhibitor (IC50: 1.23 μ... Cancer
T2456 Tivozanib Tivozanib is an orally bioavailable inhibitor of vascular endothelial growth factor r... Cancer